Free Trial

Vickers Vantage Corp. I (VCKAW) Competitors

$0.04 0.00 (0.00%)
As of 11/12/2026

VCKAW vs. SXTPW, ADTX, BFRIW, CALA, and CDT

Should you buy Vickers Vantage Corp. I stock or one of its competitors? Vickers Vantage Corp. I's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Aditxt (ADTX), Biofrontera (BFRIW), Calithera Biosciences (CALA), and CDT Equity (CDT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Vickers Vantage Corp. I compare to 60 Degrees Pharmaceuticals?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Vickers Vantage Corp. I. 60 Degrees Pharmaceuticals' average media sentiment score of 1.82 beat Vickers Vantage Corp. I's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Aditxt?

Aditxt (NASDAQ:ADTX) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

15.5% of Aditxt shares are held by institutional investors. 0.0% of Aditxt shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Vickers Vantage Corp. I has lower revenue, but higher earnings than Aditxt.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aditxt$14.34K0.02-$41.71M-$100.79 thousandN/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aditxt
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Vickers Vantage Corp. I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Vickers Vantage Corp. I has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. Vickers Vantage Corp. I's return on equity of 0.00% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
Aditxt-360,152.50% -374.60% -105.93%
Vickers Vantage Corp. I N/A N/A N/A

In the previous week, Aditxt's average media sentiment score of 0.00 equaled Vickers Vantage Corp. I'saverage media sentiment score.

Company Overall Sentiment
Aditxt Neutral
Vickers Vantage Corp. I Neutral

Summary

Aditxt beats Vickers Vantage Corp. I on 4 of the 7 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Biofrontera?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

In the previous week, Biofrontera had 4 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 4 mentions for Biofrontera and 0 mentions for Vickers Vantage Corp. I. Biofrontera's average media sentiment score of 0.93 beat Vickers Vantage Corp. I's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Biofrontera Positive

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

Summary

Biofrontera beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Calithera Biosciences?

Calithera Biosciences (OTCMKTS:CALA) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

In the previous week, Calithera Biosciences' average media sentiment score of 0.00 equaled Vickers Vantage Corp. I'saverage media sentiment score.

Company Overall Sentiment
Calithera Biosciences Neutral
Vickers Vantage Corp. I Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera BiosciencesN/AN/AN/AN/AN/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Calithera BiosciencesN/A N/A N/A
Vickers Vantage Corp. I N/A N/A N/A

Summary

Calithera Biosciences and Vickers Vantage Corp. I tied by winning 0 of the 0 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to CDT Equity?

CDT Equity (NASDAQ:CDT) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CDT EquityN/AN/A-$39.22M-$32.16 thousandN/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

Vickers Vantage Corp. I's return on equity of 0.00% beat CDT Equity's return on equity.

Company Net Margins Return on Equity Return on Assets
CDT EquityN/A -72.25% -55.44%
Vickers Vantage Corp. I N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CDT Equity
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Vickers Vantage Corp. I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

3.3% of CDT Equity shares are held by institutional investors. 0.0% of CDT Equity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, CDT Equity had 2 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 2 mentions for CDT Equity and 0 mentions for Vickers Vantage Corp. I. CDT Equity's average media sentiment score of 0.36 beat Vickers Vantage Corp. I's score of 0.00 indicating that CDT Equity is being referred to more favorably in the media.

Company Overall Sentiment
CDT Equity Neutral
Vickers Vantage Corp. I Neutral

Summary

CDT Equity beats Vickers Vantage Corp. I on 5 of the 7 factors compared between the two stocks.

Get Vickers Vantage Corp. I News Delivered to You Automatically

Sign up to receive the latest news and ratings for VCKAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VCKAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VCKAW vs. The Competition

MetricVickers Vantage Corp. IPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$13.76B$7.83B$12.01B
Dividend YieldN/A2.56%2.46%4.50%
P/E RatioN/A29.5234.4130.36
Price / SalesN/A7.528.865.82
Price / CashN/A15.7922.2322.80
Price / BookN/A4.934.393.77
Net IncomeN/A$2.87B$3.51B$390.55M
7 Day PerformanceN/A-0.33%-1.68%-0.58%
1 Month PerformanceN/A-4.31%-4.09%-6.84%
1 Year PerformanceN/A-6.73%0.66%-6.12%

Vickers Vantage Corp. I Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VCKAW
Vickers Vantage Corp. I
N/A$0.04
flat
N/A-83.7%$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
-0.4%
N/A-51.4%$0.00$1.11MN/A3
ADTX
Aditxt
0.0203 of 5 stars
$0.00
flat
N/A-100.0%$0.00$14.34KN/A26
BFRIW
Biofrontera
N/A$0.00
flat
N/AN/A$0.00$46.18MN/A94
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60

Related Companies and Tools


This page (NASDAQ:VCKAW) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners